Display options
Cite
Krotneva SP, Ramjaun A, Reidel KE, et al. Use of hormonal therapy in senior breast cancer patients treated with or without radiotherapy. Curr Oncol. 2014;21(1):e105-15doi: 10.3747/co.21.1605.
Krotneva, S. P., Ramjaun, A., Reidel, K. E., Eguale, T., Trabulsi, N., Mayo, N., Tamblyn, R., & Meguerditchian, A. N. (2014). Use of hormonal therapy in senior breast cancer patients treated with or without radiotherapy. Current oncology (Toronto, Ont.), 21(1), e105-15. https://doi.org/10.3747/co.21.1605
Krotneva, S P, et al. "Use of hormonal therapy in senior breast cancer patients treated with or without radiotherapy." Current oncology (Toronto, Ont.) vol. 21,1 (2014): e105-15. doi: https://doi.org/10.3747/co.21.1605
Krotneva SP, Ramjaun A, Reidel KE, Eguale T, Trabulsi N, Mayo N, Tamblyn R, Meguerditchian AN. Use of hormonal therapy in senior breast cancer patients treated with or without radiotherapy. Curr Oncol. 2014 Feb;21(1):e105-15. doi: 10.3747/co.21.1605. PMID: 24523607; PMCID: PMC3921034.
Copy Download .nbib Format: NLM
Share it on

Curr Oncol. 2014 Feb;21(1):e105-15. doi: 10.3747/co.21.1605.

Use of hormonal therapy in senior breast cancer patients treated with or without radiotherapy.

Current oncology (Toronto, Ont.)

S P Krotneva, A Ramjaun, K E Reidel, T Eguale, N Trabulsi, N Mayo, R Tamblyn, A N Meguerditchian

Affiliations

  1. Clinical and Health Informatics Research Group, McGill University, Montreal, QC.
  2. Clinical and Health Informatics Research Group, McGill University, Montreal, QC. ; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC.
  3. Clinical and Health Informatics Research Group, McGill University, Montreal, QC. ; Department of Medicine, McGill University, Montreal, QC.
  4. Department of Surgery, McGill University, Montreal, QC. ; Department of Surgery, King Abdul-Aziz University, Saudi Arabia.
  5. Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC. ; Department of Medicine, McGill University, Montreal, QC. ; School of Physical and Occupational Therapy, McGill University, Montreal, QC.
  6. Clinical and Health Informatics Research Group, McGill University, Montreal, QC. ; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC. ; Department of Medicine, McGill University, Montreal, QC.
  7. Clinical and Health Informatics Research Group, McGill University, Montreal, QC. ; Department of Oncology, McGill University, Montreal, QC.

PMID: 24523607 PMCID: PMC3921034 DOI: 10.3747/co.21.1605

Abstract

PURPOSE: Breast cancer treatment guidelines state that radiotherapy (rt) can reasonably be omitted in selected women 70 years of age and older if they take adjuvant endocrine therapy (aet) for 5 years. We aimed to assess persistence and adherence to aet in women 70 years of age and older, and to examine differences between rt receivers and non-receivers.

METHODS: Quebec's medical service and pharmacy claims databases were used to identify seniors undergoing breast-conserving surgery (1998-2005) and initiating aet. Cox proportional hazards models were used to identify predictors of aet non-persistence.

RESULTS: Of 3180 women who initiated aet (mean age: 77.5 years), 28% did not receive rt. During the subsequent 5 years, 32% of patients who initiated aet did not persist, 2% filled only a single prescription, and 22% switched medications. Compared with rt receivers, non-receivers discontinued more often (35.5% vs. 30.1%) and earlier (1.4 years vs. 1.6 years). They also became nonadherent earlier (medication possession ratio < 80% at year 3 vs. at year 5). Predictors of nonpersistence included rt omission [hazard ratio (hr): 1.26; 95% confidence interval (ci): 1.09 to 1.46]; age (hr per decade increase: 1.15; 95% ci: 1.01 to 1.31); new medications (hr per medication: 1.01; 95% ci: 1.00 to 1.02); and hospitalizations during aet, (hr per hospitalization: 1.08; 95% ci: 1.05 to 1.11). In a subanalysis of rt non-receivers, significant predictors included hospitalizations (hr: 1.07; 95% ci: 1.02 to 1.12) and medications at aet start (hr: 0.94; 95% ci: 0.91 to 0.97).

CONCLUSIONS: Suboptimal use of aet was observed in at least one third of women. In rt non-receivers, aet use was worse than it was in rt receivers. Initiation of new medications and hospitalizations increased the risk of non-persistence.

Keywords: Adjuvant endocrine therapy; adherence; breast cancer; persistence; radiotherapy; seniors

References

  1. J Clin Oncol. 2003 Feb 15;21(4):602-6 - PubMed
  2. Breast Cancer Res Treat. 2011 Jan;125(1):191-200 - PubMed
  3. Semin Radiat Oncol. 2012 Oct;22(4):295-303 - PubMed
  4. Med Care. 1993 Jun;31(6):498-507 - PubMed
  5. Cancer Med. 2012 Dec;1(3):318-27 - PubMed
  6. J Clin Oncol. 2007 May 10;25(14):1824-31 - PubMed
  7. J Clin Epidemiol. 1995 Aug;48(8):999-1009 - PubMed
  8. J Clin Oncol. 2003 Apr 1;21(7):1383-9 - PubMed
  9. J Clin Oncol. 2013 Jul 1;31(19):2382-7 - PubMed
  10. Lancet. 2013 Mar 9;381(9869):805-16 - PubMed
  11. Breast Cancer Res Treat. 2008 Jul;110(2):199-209 - PubMed
  12. J Epidemiol Community Health. 2007 Apr;61(4):287-96 - PubMed
  13. J Clin Oncol. 2001 Jan 15;19(2):322-8 - PubMed
  14. Cancer. 2002 Dec 15;95(12):2465-72 - PubMed
  15. J Clin Oncol. 2009 Jul 20;27(21):3445-51 - PubMed
  16. Patient Educ Couns. 2005 Oct;59(1):97-102 - PubMed
  17. Br J Cancer. 2008 Dec 2;99(11):1763-8 - PubMed
  18. J Clin Epidemiol. 1997 Jan;50(1):105-16 - PubMed
  19. J Gen Intern Med. 2006 Aug;21(8):852-6 - PubMed
  20. J Clin Oncol. 2010 Sep 20;28(27):4120-8 - PubMed
  21. J Natl Cancer Inst. 2001 Jul 4;93(13):979-89 - PubMed
  22. N Engl J Med. 1973 Nov 29;289(22):1174-8 - PubMed
  23. J Clin Oncol. 2008 Feb 1;26(4):549-55 - PubMed
  24. J Clin Oncol. 2004 Aug 15;22(16):3309-15 - PubMed
  25. Breast Cancer Res Treat. 2006 Sep;99(2):215-20 - PubMed
  26. CMAJ. 2001 Apr 17;164(8):1133-8 - PubMed
  27. Med Care. 2005 Nov;43(11):1130-9 - PubMed
  28. Chronic Dis Can. 2009;29(4):178-91 - PubMed
  29. J Clin Oncol. 2002 Jun 1;20(11):2680-8 - PubMed
  30. Value Health. 2008 Jan-Feb;11(1):44-7 - PubMed
  31. Breast Cancer Res Treat. 2013 Feb;138(1):325-8 - PubMed
  32. Am J Public Health. 1996 Dec;86(12):1805-8 - PubMed
  33. Breast. 2008 Aug;17(4):376-81 - PubMed
  34. Arch Intern Med. 1994 Feb 28;154(4):433-7 - PubMed
  35. N Engl J Med. 2004 Sep 2;351(10):971-7 - PubMed
  36. Expert Opin Drug Saf. 2007 Nov;6(6):695-704 - PubMed
  37. Ann Oncol. 2009 Mar;20(3):431-6 - PubMed
  38. J Clin Oncol. 2008 Feb 1;26(4):556-62 - PubMed

Publication Types